Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133696) titled 'Evaluation Study of Weizmannia coagulans BC99 on Protein Digestion, Metabolism, and Exercise Performance' on Sept. 30.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The first affiliated Hospital of henan university of science & technology
Condition:
none
Intervention:
placebo group:placebo milk protein powder
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-30
Target Sample Size: placebo group:30;BC99 group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345785
Published by HT Digital Co...